These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32486108)

  • 1. 1-Hydroxyanthraquinones Containing Aryl Substituents as Potent and Selective Anticancer Agents.
    Sirazhetdinova NS; Savelyev VA; Frolova TS; Baev DS; Klimenko LS; Chernikov IV; Oleshko OS; Sarojan TA; Pokrovskii AG; Shults EE
    Molecules; 2020 May; 25(11):. PubMed ID: 32486108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel hydroxyanthraquinone nitrogen mustard derivatives as potential anticancer agents via a bioisostere approach.
    Zhao LM; Ma FY; Jin HS; Zheng S; Zhong Q; Wang G
    Eur J Med Chem; 2015 Sep; 102():303-9. PubMed ID: 26291039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and cytotoxic effect of hydroxy- and 3-alkylaminopropoxy-9,10-anthraquinone derivatives.
    Teng CH; Won SJ; Lin CN
    Bioorg Med Chem; 2005 May; 13(10):3439-45. PubMed ID: 15848756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and biological study of synthesized anthraquinone series of compounds with sulfonamide feature.
    Awasthi P; Vatsal M; Sharma A
    J Biomol Struct Dyn; 2019 Oct; 37(17):4465-4480. PubMed ID: 30489230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.
    Huang HS; Huang KF; Li CL; Huang YY; Chiang YH; Huang FC; Lin JJ
    Bioorg Med Chem; 2008 Jul; 16(14):6976-86. PubMed ID: 18571928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, anticancer evaluation and mechanisms of cytotoxic activity of novel 3-hydroxy-3-pyrrolin-2-ones bearing thenoyl fragment: DNA, BSA interactions and molecular docking study.
    Joksimović N; Petronijević J; Janković N; Baskić D; Popović S; Todorović D; Matić S; Bogdanović GA; Vraneš M; Tot A; Bugarčić Z
    Bioorg Chem; 2019 Jul; 88():102954. PubMed ID: 31054428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amides of pyrrole- and thiophene-fused anthraquinone derivatives: A role of the heterocyclic core in antitumor properties.
    Tikhomirov AS; Litvinova VA; Andreeva DV; Tsvetkov VB; Dezhenkova LG; Volodina YL; Kaluzhny DN; Treshalin ID; Schols D; Ramonova AA; Moisenovich MM; Shtil AA; Shchekotikhin AE
    Eur J Med Chem; 2020 Aug; 199():112294. PubMed ID: 32428792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, Synthesis, Molecular Docking, and Biological Evaluation of New Emodin Anthraquinone Derivatives as Potential Antitumor Substances.
    Li Y; Guo F; Chen T; Zhang L; Wang Z; Su Q; Feng L
    Chem Biodivers; 2020 Sep; 17(9):e2000328. PubMed ID: 32627416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel bis-anthraquinone derivatives and their biological evaluation as antitumor agents.
    Taher AT; Hegazy GH
    Arch Pharm Res; 2013 May; 36(5):573-8. PubMed ID: 23471561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones.
    Toan DN; Thanh ND; Truong MX; Van DT
    Med Chem; 2022; 18(1):36-50. PubMed ID: 33380305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and cytotoxic effect of 1,3-dihydroxy-9,10-anthraquinone derivatives.
    Wei BL; Wu SH; Chung MI; Won SJ; Lin CN
    Eur J Med Chem; 2000 Dec; 35(12):1089-98. PubMed ID: 11248407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the aryl substituent on antitumor activity of 2-substituted-1,4-dihydroxy-9,10-anthraquinones and 2-substituted-anthracene-1,4,9,10-tetraones.
    Nam NH; Jin GZ; Tam MN; Ahn BZ
    Arch Pharm Res; 1999 Dec; 22(6):592-607. PubMed ID: 10615866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiophene-2-carboxamide derivatives of anthraquinone: A new potent antitumor chemotype.
    Volodina YL; Tikhomirov AS; Dezhenkova LG; Ramonova AA; Kononova AV; Andreeva DV; Kaluzhny DN; Schols D; Moisenovich MM; Shchekotikhin AE; Shtil AA
    Eur J Med Chem; 2021 Oct; 221():113521. PubMed ID: 34082225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, DNA binding, and cytotoxicity studies of pyrrolo[2,1-c][1,4]benzodiazepine-anthraquinone conjugates.
    Kamal A; Ramu R; Tekumalla V; Khanna GB; Barkume MS; Juvekar AS; Zingde SM
    Bioorg Med Chem; 2007 Nov; 15(22):6868-75. PubMed ID: 17822905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
    Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
    Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annulation of substituted anthracene-9,10-diones yields promising selectively antiproliferative compounds.
    Castro-Castillo V; Suárez-Rozas C; Castro-Loiza N; Theoduloz C; Cassels BK
    Eur J Med Chem; 2013 Apr; 62():688-92. PubMed ID: 23454511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Anthraquinone Derivatives as Dual Inhibitors of Topoisomerase 2 and Casein Kinase 2: In Silico Studies, Synthesis and Biological Evaluation on Leukemic Cell Lines.
    Kabir A; Tilekar K; Upadhyay N; Ramaa CS
    Anticancer Agents Med Chem; 2018; 18(11):1551-1562. PubMed ID: 29683096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antitumor anthra[2,3-b]furan-3-carboxamides: Synthesis and structure-activity relationship.
    Tikhomirov AS; Lin CY; Volodina YL; Dezhenkova LG; Tatarskiy VV; Schols D; Shtil AA; Kaur P; Chueh PJ; Shchekotikhin AE
    Eur J Med Chem; 2018 Mar; 148():128-139. PubMed ID: 29459273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antiproliferative activity of 1,4-bis(dimethylamino)-9,10-anthraquinone derivatives against P388 mouse leukemic tumor cells.
    Jin GZ; Jin HS; Jin LL
    Arch Pharm Res; 2011 Jul; 34(7):1071-6. PubMed ID: 21811913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells.
    Tu HY; Huang AM; Teng CH; Hour TC; Yang SC; Pu YS; Lin CN
    Bioorg Med Chem; 2011 Sep; 19(18):5670-8. PubMed ID: 21852140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.